Title : ( Gasdermin E as a potential target and biomarker for CRISPR-Cas9-based cancer therapy )
Authors: Mojtaba Tarin , Amir SHokooh Saljooghi ,Access to full-text not allowed by authors
Abstract
Gasdermin E (GSDME), a protein pivotal in mediating pyroptosis, has gained significant attention due to its role in cancer pathogenesis and its potential as a therapeutic target. The advent of CRISPR-Cas9, a precise genome editing tool, has revolutionized cancer therapy by enabling the manipulation of GSDME expression and function. This review explores the interplay of GSDME and CRISPR-Cas9 in cancer, emphasizing GSDME’s unique mechanism of cleavage-dependent pore formation in the cell membrane and its emerging applications as both a therapeutic target and a diagnostic biomarker. We discuss the potential and challenges of using GSDME-induced pyroptosis as a therapeutic strategy and how can enhance its efficacy and specificity. We conclude by highlighting promising future research directions in this emerging field.
Keywords
, gasdermin E, CRISPR-Cas9, cancer, cell death, inflammation, pyroptosis, gene editing@article{paperid:1102942,
author = {Tarin, Mojtaba and SHokooh Saljooghi, Amir},
title = {Gasdermin E as a potential target and biomarker for CRISPR-Cas9-based cancer therapy},
journal = {Biochemical Pharmacology},
year = {2025},
month = {April},
issn = {0006-2952},
keywords = {gasdermin E; CRISPR-Cas9; cancer; cell death; inflammation; pyroptosis; gene editing},
}
%0 Journal Article
%T Gasdermin E as a potential target and biomarker for CRISPR-Cas9-based cancer therapy
%A Tarin, Mojtaba
%A SHokooh Saljooghi, Amir
%J Biochemical Pharmacology
%@ 0006-2952
%D 2025